ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Quantum Genomics

Quantum Genomics (ALQGC)

0.0721
0.00
(0.00%)
終了 12月4日 1:30AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.0721
買値
0.0068
売値
0.1096
出来高
0.00
0.00 日の範囲 0.00
0.001 52 週間の範囲 0.1578
時価総額
前日終値
0.0721
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,371,851
発行済株式数
69,709,954
配当利回り
-
PER
-1.54
1 株当たり利益 (EPS)
-0.05
歳入
36k
純利益
-3.17M

Quantum Genomics について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Paris, Paris, Fra
設立
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.1578 €.

Quantum Genomics currently has 69,709,954 shares in issue. The market capitalisation of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -1.54.

ALQGC 最新ニュース

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
120.05814150.0140.1380.0113718510.05761207DE
26-0.0399-35.6250.1120.1380.0017878480.0516184DE
52-0.0279-27.90.10.15780.0014480420.05830021DE
156-4.3199-98.35837887074.3924.5640.0013152480.49116958DE
260-3.1079-97.73270440253.186.1850.0013108511.80709422DE

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

最近閲覧した銘柄

Delayed Upgrade Clock